These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8150631)

  • 1. [Comment on the contribution by Th. Rosenbach et al. Treatment of vitiligo with phenylalanine and UV-A].
    Ochsendorf F
    Hautarzt; 1994 Feb; 45(2):123. PubMed ID: 8150631
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of vitiligo with phenylalanine and UV-A].
    Rosenbach T; Wellenreuther U; Nürnberger F; Czarnetzki BM
    Hautarzt; 1993 Apr; 44(4):208-9. PubMed ID: 8482598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vitiligo therapy with phenylalanine/UV A. Catamnestic studies after five years].
    Greiner D; Ochsendorf FR; Milbradt R
    Hautarzt; 1994 Jul; 45(7):460-3. PubMed ID: 7928339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylalanine and UVA for Vitiligo patients: probability of an effective treatment.
    Reuss S; Weiss C; Bayerl C
    Med Hypotheses; 2006; 67(1):199-200. PubMed ID: 16554122
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of an antioxidant and mitochondria-stimulating cream formula on the skin of patients with stable common vitiligo].
    Rojas-Urdaneta JE; Poleo-Romero AG
    Invest Clin; 2007 Mar; 48(1):21-31. PubMed ID: 17432541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Repigmentation treatment of vitiligo with L-phenylalanine and UVA irradiation].
    Thiele B; Steigleder GK
    Z Hautkr; 1987 Apr; 62(7):519-23. PubMed ID: 3590916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tacrolimus on vitiligo in absence of UV radiation exposure.
    Sardana K; Bhushan P; Kumar Garg V
    Arch Dermatol; 2007 Jan; 143(1):119; author reply 120. PubMed ID: 17224558
    [No Abstract]   [Full Text] [Related]  

  • 8. A case study to evaluate the treatment of vitiligo with khellin encapsulated in L-phenylalanin stabilized phosphatidylcholine liposomes in combination with ultraviolet light therapy.
    de Leeuw J; van der Beek N; Maierhofer G; Neugebauer WD
    Eur J Dermatol; 2003; 13(5):474-7. PubMed ID: 14693493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultraviolet A in vitiligo.
    El-Mofty M; Mostafa W; Youssef R; El-Fangary M; Elramly AZ; Mahgoub D; Fawzy M
    Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):214-6. PubMed ID: 16869873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitiligo: new and emerging treatments.
    Lotti T; Gori A; Zanieri F; Colucci R; Moretti S
    Dermatol Ther; 2008; 21(2):110-7. PubMed ID: 18394085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of vitiligo using phenylalanine and UVA irradiation].
    Biella U; Haustein UF
    Hautarzt; 1990 Nov; 41(11):636. PubMed ID: 2276919
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model.
    Faas L; Venkatasamy R; Hider RC; Young AR; Soumyanath A
    Br J Dermatol; 2008 May; 158(5):941-50. PubMed ID: 18284389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of phenol to induce pigmentation in vitiligo.
    Mysore V
    J Cosmet Dermatol; 2002 Jul; 1(2):99-100. PubMed ID: 17147530
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
    Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narrowband UVB therapy for vitiligo: does the repigmentation last?
    Sitek JC; Loeb M; Ronnevig JR
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):891-6. PubMed ID: 17658996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.
    Dell'Anna ML; Mastrofrancesco A; Sala R; Venturini M; Ottaviani M; Vidolin AP; Leone G; Calzavara PG; Westerhof W; Picardo M
    Clin Exp Dermatol; 2007 Nov; 32(6):631-6. PubMed ID: 17953631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients.
    Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P
    Br J Dermatol; 2005 May; 152(5):981-5. PubMed ID: 15888156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
    Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
    J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight--a new study for the treatment of vitiligo.
    Camacho F; Mazuecos J
    J Drugs Dermatol; 2002 Sep; 1(2):127-31. PubMed ID: 12847735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.